Readystate Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$398K Buy
9,321
+5,781
+163% +$314K 0.01% 711
2026
Q1
$222K Buy
+3,540
New +$283K 0.01% 735
2025
Q2
Sell
-2,823
Closed -$285K 656
2025
Q1
$285K Buy
+2,823
New +$284K 0.01% 544

Other funds holding BSX

Readystate Asset Management's BSX Position: Q2 2026 in Review

Readystate Asset Management increased its Boston Scientific (BSX) stake by 163% in Q2 2026, buying an estimated $314K and bringing the position to 9,321 shares worth $398K. The position accounts for 0.01% of the portfolio, ranked #711.

Readystate Asset Management first reported a position in BSX in Q1 2025 and has held it in 3 quarters since. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Readystate Asset Management held 9,321 shares of Boston Scientific worth $398K as of Q2 2026.
  • Readystate Asset Management bought 5,781 Boston Scientific shares in Q2 2026, an estimated $314K.
  • Boston Scientific made up 0.01% of Readystate Asset Management's portfolio in Q2 2026, its #711 holding.
  • Readystate Asset Management first reported a position in Boston Scientific in Q1 2025 and has held it in 3 quarters since.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Readystate Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.